Exact Mass: 585.4604

Exact Mass Matches: 585.4604

Found 129 metabolites which its exact mass value is equals to given mass value 585.4604, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cer(d17:1/20:4(6E,8Z,11Z,14Z)+=O(5))

(6E,8Z,11Z,14Z)-N-[(2S,3R,4E)-1,3-dihydroxyheptadec-4-en-2-yl]-5-oxoicosa-6,8,11,14-tetraenamide

C37H63NO4 (585.4757)


Cer(d17:1/20:4(6E,8Z,11Z,14Z)+=O(5)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d17:1/20:4(5Z,8Z,11Z,13E)+=O(15))

(5Z,8Z,11Z,13E)-N-[(2S,3R,4E)-1,3-dihydroxyheptadec-4-en-2-yl]-15-oxoicosa-5,8,11,13-tetraenamide

C37H63NO4 (585.4757)


Cer(d17:1/20:4(5Z,8Z,11Z,13E)+=O(15)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(5Z,8Z,11Z,14Z,16E,18R)-N-[(2S,3R,4E)-1,3-dihydroxyheptadec-4-en-2-yl]-18-hydroxyicosa-5,8,11,14,16-pentaenamide

C37H63NO4 (585.4757)


Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(5Z,8Z,11Z,13E,17Z)-N-[(2S,3R,4E)-1,3-dihydroxyheptadec-4-en-2-yl]-16-hydroxyicosa-5,8,11,13,17-pentaenamide

C37H63NO4 (585.4757)


Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d17:1/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(5Z,8Z,10E,14Z,17Z)-N-[(2S,3R,4E)-1,3-dihydroxyheptadec-4-en-2-yl]-12-hydroxyicosa-5,8,10,14,17-pentaenamide

C37H63NO4 (585.4757)


Cer(d17:1/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d17:1/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(6E,8Z,11Z,14Z,17Z)-N-[(2S,3R,4E)-1,3-dihydroxyheptadec-4-en-2-yl]-5-hydroxyicosa-6,8,11,14,17-pentaenamide

C37H63NO4 (585.4757)


Cer(d17:1/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

3,7,11-tris(2-hydroxyethyl)-15-oxa-3,7,11-triazaheptacosane-1,13-diol hydrochloride

3,7,11-tris(2-hydroxyethyl)-15-oxa-3,7,11-triazaheptacosane-1,13-diol hydrochloride

C29H64ClN3O6 (585.4483)


   

ALUMINUM DILINOLEATE

ALUMINUM DILINOLEATE

C36H62AlO4-- (585.4463)


   

Cer(d17:1/20:4(6E,8Z,11Z,14Z)+=O(5))

Cer(d17:1/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H63NO4 (585.4757)


   

Cer(d17:1/20:4(5Z,8Z,11Z,13E)+=O(15))

Cer(d17:1/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H63NO4 (585.4757)


   

Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C37H63NO4 (585.4757)


   

Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

Cer(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C37H63NO4 (585.4757)


   

Cer(d17:1/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

Cer(d17:1/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C37H63NO4 (585.4757)


   

Cer(d17:1/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

Cer(d17:1/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C37H63NO4 (585.4757)


   
   

HexCer 18:2;2O/8:0

HexCer 18:2;2O/8:0

C32H59NO8 (585.424)


   

HexCer 24:2;2O/2:0

HexCer 24:2;2O/2:0

C32H59NO8 (585.424)


   

HexCer 19:2;2O/7:0

HexCer 19:2;2O/7:0

C32H59NO8 (585.424)


   

HexCer 22:2;2O/4:0

HexCer 22:2;2O/4:0

C32H59NO8 (585.424)


   

HexCer 8:1;2O/18:1

HexCer 8:1;2O/18:1

C32H59NO8 (585.424)


   

HexCer 23:2;2O/3:0

HexCer 23:2;2O/3:0

C32H59NO8 (585.424)


   

HexCer 8:0;2O/18:2

HexCer 8:0;2O/18:2

C32H59NO8 (585.424)


   

HexCer 21:2;2O/5:0

HexCer 21:2;2O/5:0

C32H59NO8 (585.424)


   

HexCer 20:2;2O/6:0

HexCer 20:2;2O/6:0

C32H59NO8 (585.424)


   

HexCer 9:0;2O/17:2

HexCer 9:0;2O/17:2

C32H59NO8 (585.424)


   

HexCer 9:1;2O/17:1

HexCer 9:1;2O/17:1

C32H59NO8 (585.424)


   

HexCer 17:2;2O/9:0

HexCer 17:2;2O/9:0

C32H59NO8 (585.424)


   

NAGly 22:5/12:0

NAGly 22:5/12:0

C36H59NO5 (585.4393)


   

NAGly 16:2/18:3

NAGly 16:2/18:3

C36H59NO5 (585.4393)


   

NAGly 24:5/10:0

NAGly 24:5/10:0

C36H59NO5 (585.4393)


   

NAGly 18:5/16:0

NAGly 18:5/16:0

C36H59NO5 (585.4393)


   

NAGly 18:2/16:3

NAGly 18:2/16:3

C36H59NO5 (585.4393)


   

NAGly 16:4/18:1

NAGly 16:4/18:1

C36H59NO5 (585.4393)


   

NAGly 16:3/18:2

NAGly 16:3/18:2

C36H59NO5 (585.4393)


   

NAGly 20:4/14:1

NAGly 20:4/14:1

C36H59NO5 (585.4393)


   

NAGly 18:4/16:1

NAGly 18:4/16:1

C36H59NO5 (585.4393)


   

NAGly 20:5/14:0

NAGly 20:5/14:0

C36H59NO5 (585.4393)


   

NAGly 18:3/16:2

NAGly 18:3/16:2

C36H59NO5 (585.4393)


   

NAGly 14:1/20:4

NAGly 14:1/20:4

C36H59NO5 (585.4393)


   

NAGly 12:0/22:5

NAGly 12:0/22:5

C36H59NO5 (585.4393)


   

[2-hydroxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-hydroxy-3-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H60NO6P (585.4158)


   

HexCer 11:1;2O/15:1

HexCer 11:1;2O/15:1

C32H59NO8 (585.424)


   

HexCer 16:2;2O/10:0

HexCer 16:2;2O/10:0

C32H59NO8 (585.424)


   

HexCer 13:2;2O/13:0

HexCer 13:2;2O/13:0

C32H59NO8 (585.424)


   

HexCer 10:0;2O/16:2

HexCer 10:0;2O/16:2

C32H59NO8 (585.424)


   

HexCer 12:2;2O/14:0

HexCer 12:2;2O/14:0

C32H59NO8 (585.424)


   

HexCer 12:1;2O/14:1

HexCer 12:1;2O/14:1

C32H59NO8 (585.424)


   

HexCer 13:1;2O/13:1

HexCer 13:1;2O/13:1

C32H59NO8 (585.424)


   

HexCer 15:2;2O/11:0

HexCer 15:2;2O/11:0

C32H59NO8 (585.424)


   

HexCer 10:1;2O/16:1

HexCer 10:1;2O/16:1

C32H59NO8 (585.424)


   

2-[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C32H59NO8 (585.424)


   

2-[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

2-[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C32H59NO8 (585.424)


   

(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid

(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tetradecane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tetradecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(octadecanoylamino)pentadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(octadecanoylamino)pentadeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(tridecanoylamino)icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(tridecanoylamino)icosa-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyundecane-1-sulfonic acid

2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyundecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-2-(decanoylamino)-3-hydroxytricosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-(decanoylamino)-3-hydroxytricosa-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-2-(dodecanoylamino)-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-(dodecanoylamino)-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tetradec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tetradec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]octadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]octadec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tridec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tridec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid

(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyundec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]nonadec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-2-(henicosanoylamino)-3-hydroxydodeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-(henicosanoylamino)-3-hydroxydodeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]pentadecane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]pentadecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxydodecane-1-sulfonic acid

2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxydodecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-2-(hexadecanoylamino)-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-(hexadecanoylamino)-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]pentadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]pentadec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]icos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]icos-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(pentadecanoylamino)octadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(pentadecanoylamino)octadeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(nonadecanoylamino)tetradeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(nonadecanoylamino)tetradeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(undecanoylamino)docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(undecanoylamino)docosa-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhexadecane-1-sulfonic acid

2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhexadecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(icosanoylamino)trideca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(icosanoylamino)trideca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid

(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-3-hydroxy-2-(tetradecanoylamino)nonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(tetradecanoylamino)nonadeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(4E,8E)-2-(heptadecanoylamino)-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-(heptadecanoylamino)-3-hydroxyhexadeca-4,8-diene-1-sulfonic acid

C33H63NO5S (585.4427)


   

(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhexadec-4-ene-1-sulfonic acid

(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhexadec-4-ene-1-sulfonic acid

C33H63NO5S (585.4427)


   

3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tridecane-1-sulfonic acid

3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tridecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyheptadecane-1-sulfonic acid

2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyheptadecane-1-sulfonic acid

C33H63NO5S (585.4427)


   

HexCer 14:2;2O/12:0

HexCer 14:2;2O/12:0

C32H59NO8 (585.424)


   

4-(2-Icosanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Icosanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(2-Octadecanoyloxy-3-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Octadecanoyloxy-3-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Butanoyloxy-2-nonadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Butanoyloxy-2-nonadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Octanoyloxy-2-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Octanoyloxy-2-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(2-Heptadecanoyloxy-3-hexanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Heptadecanoyloxy-3-hexanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Nonanoyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Nonanoyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Acetyloxy-2-henicosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-henicosanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Heptanoyloxy-2-hexadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Heptanoyloxy-2-hexadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(2-Dodecanoyloxy-3-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Dodecanoyloxy-3-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Decanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Decanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]dodec-5-enamide

(Z)-N-[(E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradec-4-en-2-yl]dodec-5-enamide

C32H59NO8 (585.424)


   

4-(2-Decanoyloxy-3-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Decanoyloxy-3-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

4-(3-Dodecanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Dodecanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C33H63NO7 (585.4604)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8-dien-2-yl]decanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8-dien-2-yl]decanamide

C32H59NO8 (585.424)


   

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]dodecanamide

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]dodecanamide

C32H59NO8 (585.424)


   

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]dodecanamide

N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]dodecanamide

C32H59NO8 (585.424)


   

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,6-dien-2-yl]decanamide

N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,6-dien-2-yl]decanamide

C32H59NO8 (585.424)


   
   

DGTS 22:1;O

DGTS 22:1;O

C32H59NO8 (585.424)


   
   
   
   

CerP 14:0;O2/18:3

CerP 14:0;O2/18:3

C32H60NO6P (585.4158)


   

CerP 14:1;O2/18:2

CerP 14:1;O2/18:2

C32H60NO6P (585.4158)


   

CerP 14:2;O2/18:1

CerP 14:2;O2/18:1

C32H60NO6P (585.4158)


   

CerP 15:1;O2/17:2

CerP 15:1;O2/17:2

C32H60NO6P (585.4158)


   

CerP 15:2;O2/17:1

CerP 15:2;O2/17:1

C32H60NO6P (585.4158)


   

CerP 16:2;O2/16:1

CerP 16:2;O2/16:1

C32H60NO6P (585.4158)


   

CerP 17:2;O2/15:1

CerP 17:2;O2/15:1

C32H60NO6P (585.4158)


   

CerP 18:2;O2/14:1

CerP 18:2;O2/14:1

C32H60NO6P (585.4158)


   
   

Cer 15:0;O3/22:6

Cer 15:0;O3/22:6

C37H63NO4 (585.4757)


   
   

GalCer 14:2;O2/12:0

GalCer 14:2;O2/12:0

C32H59NO8 (585.424)


   

GalCer 15:2;O2/11:0

GalCer 15:2;O2/11:0

C32H59NO8 (585.424)


   

GalCer 16:2;O2/10:0

GalCer 16:2;O2/10:0

C32H59NO8 (585.424)


   

GalCer 26:2;O2

GalCer 26:2;O2

C32H59NO8 (585.424)


   

GlcCer 14:2;O2/12:0

GlcCer 14:2;O2/12:0

C32H59NO8 (585.424)


   

GlcCer 15:2;O2/11:0

GlcCer 15:2;O2/11:0

C32H59NO8 (585.424)


   

GlcCer 16:2;O2/10:0

GlcCer 16:2;O2/10:0

C32H59NO8 (585.424)


   

GlcCer 26:2;O2

GlcCer 26:2;O2

C32H59NO8 (585.424)


   

HexCer 14:2;O2/12:0

HexCer 14:2;O2/12:0

C32H59NO8 (585.424)


   

HexCer 15:2;O2/11:0

HexCer 15:2;O2/11:0

C32H59NO8 (585.424)


   

HexCer 16:2;O2/10:0

HexCer 16:2;O2/10:0

C32H59NO8 (585.424)


   

HexCer 26:2;O2

HexCer 26:2;O2

C32H59NO8 (585.424)


   
   

(6e,10e,12e,14e,16e,18e,20e,22e,24e,26e,28e)-2-hydroxy-31-methoxy-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,10,12,14,16,18,20,22,24,26,28-undecaen-3-yl

(6e,10e,12e,14e,16e,18e,20e,22e,24e,26e,28e)-2-hydroxy-31-methoxy-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,10,12,14,16,18,20,22,24,26,28-undecaen-3-yl

C41H61O2 (585.4671)